FDA To Adopt Cost-Effectiveness Role? Congress May Revisit Issue, Crawford Says

Medicare reform will link FDA more closely with CMS, which could necessitate FDA becoming more economically aware of approval decisions, Acting Commissioner Crawford says. FDAer envisions a relationship with CMS that is akin to a merger.

More from Archive

More from Pink Sheet